| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0061 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |